VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 37 filers reported holding VERONA PHARMA PLC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $118,000 | -35.9% | 18,035 | -18.0% | 0.01% | -40.0% |
| Q1 2021 | $184,000 | +119.0% | 22,000 | +83.3% | 0.01% | +42.9% |
| Q4 2020 | $84,000 | -68.9% | 12,000 | -72.3% | 0.01% | -73.1% |
| Q3 2020 | $270,000 | -47.2% | 43,300 | -60.3% | 0.03% | -45.8% |
| Q2 2020 | $511,000 | +75.0% | 109,100 | +53.8% | 0.05% | +37.1% |
| Q1 2020 | $292,000 | -37.3% | 70,950 | -12.5% | 0.04% | -14.6% |
| Q4 2019 | $466,000 | +235.3% | 81,100 | +167.5% | 0.04% | +192.9% |
| Q3 2019 | $139,000 | +12.1% | 30,315 | +24.7% | 0.01% | +16.7% |
| Q2 2019 | $124,000 | -23.0% | 24,315 | -2.0% | 0.01% | -29.4% |
| Q1 2019 | $161,000 | +26.8% | 24,800 | +75.5% | 0.02% | +6.2% |
| Q4 2018 | $127,000 | – | 14,130 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,332,485 | $34,817,833 | 22.99% |
| Abingworth LLP | 2,457,500 | $64,214,475 | 20.92% |
| Fairmount Funds Management LLC | 2,875,526 | $75,137,494 | 11.92% |
| Octagon Capital Advisors LP | 2,468,000 | $64,488,840 | 10.04% |
| NEA Management Company, LLC | 5,584,753 | $145,929,596 | 8.20% |
| Knoll Capital Management, LLC | 95,391 | $2,492,567 | 5.62% |
| Frazier Life Sciences Management, L.P. | 2,815,720 | $73,574,764 | 4.57% |
| Resolute Capital Asset Partners LLC | 185,992 | $4,860 | 4.34% |
| Caligan Partners LP | 183,064 | $4,783,462 | 3.98% |
| Samsara BioCapital, LLC | 695,001 | $18,160,376 | 3.91% |